Editorial: Lung adenocarcinoma: from genomics to immunotherapy

Editorial: Lung adenocarcinoma: from genomics to immunotherapy

Bibliographic Details
Main Authors:	Yiming Meng, Maria Palmieri, Elisa Frullanti
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Genetics
Subjects:	solid cancer cancer biomarkers cancer prognosis disease monitoring lung cancer precision medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2024.1399127/full

Similar Items

Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine
by: Chiara Nicolazzo, et al.
Published: (2024-11-01)

Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era
by: Maria Palmieri, et al.
Published: (2023-01-01)

Editorial: Current trends and future perspectives about liquid biopsy
by: Elisa Frullanti, et al.
Published: (2023-12-01)

Editorial: Pharmacogenetic landscape in human solid cancers
by: Elena Lastraioli, et al.
Published: (2024-01-01)

Editorial: Novel immune markers and predictive models for immunotherapy and prognosis in breast and gynecological cancers
by: Fuhao Wang, et al.
Published: (2024-05-01)

Editorial: Impact of immunotherapy in lung cancer
by: Marion Ferreira, et al.
Published: (2022-11-01)

Integration of genomic aberrations to predict clinical outcomes for patients with gastroesophageal adenocarcinoma receiving neoadjuvant chemotherapy
by: E.C. Smyth, et al.
Published: (2024-03-01)

Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas
by: Elisa Dama, et al.
Published: (2020-12-01)

Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosisResearch in context
by: Xiaoshuang Feng, et al.
Published: (2023-06-01)

The landscape of actionable genomic alterations in lung adenocarcinomas in India
by: Rakesh Sharma, et al.
Published: (2023-12-01)

Immunotherapy for lung adenocarcinoma patients with bone metastases: who really needs it
by: Zhangheng Huang, et al.
Published: (2024-12-01)

Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy
by: Xian-Yang Qin, et al.
Published: (2023-04-01)

Editorial: Liquid biopsy and new omics technologies in vascular malformations
by: Massimo Vaghi, et al.
Published: (2024-09-01)

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis
by: Maria Palmieri, et al.
Published: (2022-10-01)

Comprehensive analysis of gene expression and DNA methylation data identifies potential biomarkers and functional epigenetic modules for lung adenocarcinoma
by: XiaoCong Wang, et al.

LRP1B Suppresses Immunotherapy Efficacy in Lung Adenocarcinoma by Preventing Ferroptosis
by: Zi‐Hao Ke, et al.
Published: (2024-12-01)

Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer
by: Diletta Favero, et al.
Published: (2023-11-01)

Editorial: Novel biomarkers for potential clinical applications in lung cancer
by: Hongda Liu, et al.
Published: (2024-09-01)

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer
by: Qinglin Shen, et al.
Published: (2023-06-01)

TIMP1 is an early biomarker for detection and prognosis of lung cancer
by: Ezequiel Dantas, et al.
Published: (2023-10-01)

Advances in biomarkers for immunotherapy in small-cell lung cancer
by: Hui Li, et al.
Published: (2024-12-01)

A blood test measuring DNA methylation of BCAT1 and IKZF1 for detection of lung adenocarcinoma
by: Faridh Raja Mohamed, et al.
Published: (2024-01-01)

Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma
by: Hyun Woo Jeon, et al.
Published: (2022-09-01)

Lung cancer organoids: models for preclinical research and precision medicine
by: Yajing Liu, et al.
Published: (2023-10-01)

Research progress and translational application ofmolecular markers of lung cancer
by: Cui Guohui, et al.
Published: (2020-12-01)

Integrated analysis of single-cell and bulk-RNA sequencing for the cellular senescence in prognosis of lung adenocarcinoma
by: Fengqiang Yu, et al.
Published: (2025-01-01)

Editorial: Cancer genomics in the era of precision medicine
by: Omar M. Khan, et al.
Published: (2024-02-01)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
by: Dominik Andreas Barth, et al.
Published: (2020-08-01)

Immunotherapy Advances in Small Cell Lung Cancer
by: Yangyang XU, et al.
Published: (2020-11-01)

Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung Adenocarcinoma
by: Benedikt Niedermaier, et al.
Published: (2025-01-01)

The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma
by: Atakan Topcu, et al.
Published: (2022-10-01)

Biomarkers for immunotherapy resistance in non-small cell lung cancer
by: Catriona Rother, et al.
Published: (2024-12-01)

The advances in immunotherapy biomarkers of small cell lung cancer
by: XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia
Published: (2021-07-01)

Cross-omics strategies and personalised options for lung cancer immunotherapy
by: Yalan Yan, et al.
Published: (2024-09-01)

Pulmonary adenocarcinoma possibly developed from the cut-end of small-sized adenocarcinoma in the lung periphery as recurrence 13 years after its wedge resection
by: Takaomi Hanaoka, et al.
Published: (2018-01-01)

Two Decades of Progress in Personalized Medicine of Colorectal Cancer in Serbia—Insights from the Institute for Oncology and Radiology of Serbia
by: Milena Cavic, et al.
Published: (2024-10-01)

Editorial: Immunotherapy and multimodality therapy for lung cancer
by: Chenghu Song, et al.
Published: (2024-01-01)

Orthotopic Models Using New, Murine Lung Adenocarcinoma Cell Lines Simulate Human Non-Small Cell Lung Cancer Treated with Immunotherapy
by: Eric P. Knott, et al.
Published: (2024-06-01)

Tertiary lymphoid structures: new immunotherapy biomarker
by: Fangyuan Yang, et al.
Published: (2024-07-01)

Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening
by: Yuhong Dou, et al.
Published: (2018-07-01)